The Leukemia & Lymphoma Society's Translational Research Program was established to encourage and provide support for new and novel clinical research. The goal of the program is to accelerate transfer of findings from the laboratory to clinical application. The program's purpose is to fund research that shows high promise for translating basic biomedical knowledge to prevention or new treatments and, ultimately, to prolong and enhance life. Awards will be limited to a maximum of $200,000, which include direct costs and a maximum overhead of $20,000 or 11.1 per cent of direct costs per year for three years.
Address: Director of Research Administration
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
Telephone: +1 914 821 8843
Fax: +1 914 821 8946